Uncovering the coevolution of the microenvironment in breast cancer metastasis: toward discovery of novel therapeutic targets

The Weizmann Institute of Science received a $896,775 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2021 through June 2024 to uncover the coevolution of the microenvironment in breast cancer metastasis, with the goal of discovering novel therapeutic targets. Through basic, applied, and advanced biomedical research support, the Military Medical Research and Development program aims to transform military and public health care by investigating medical solutions for the battlefield and developing impactful research. This particular award will support the Weizmann Institute of Science in conducting research that could further those goals by advancing understanding and treatment of breast cancer, a significant medical issue both for the general population and military members.